Prostate Cancer Video Channel
Explore the latest insights and summaries from experts in Prostate Cancer.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
Jason Hafron
Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospects for 2025
- 677 views
- December 16, 2024
- 3
Oncology 2024 Year in Review
Year in Review 2024 - Managing Advanced Prostate Cancer
FEATURING
Robert Dreicer
- 447 views
- December 18, 2024
- 3
Yale Cancer Center
Surgical Management of High-Risk and Locally Advanced Prostate Cancer
FEATURING
Isaac Kim
- 555 views
- September 23, 2024
- 3
Advanced Prostate Cancer Consensus Conference (APCCC)
Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC
FEATURING
Karim Fizazi
- 348 views
- November 19, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mCRPC) and NIAGARA (MIBC)
FEATURING
Robert Dreicer
- 388 views
- September 24, 2024
- 4
Penn Medicine Abramson Cancer Center
Advances in Prostate Cancer Surgery
FEATURING
Benjamin Schurhamer,
Thomas Guzzo
- 262 views
- November 11, 2024
- 4
Insights from 2024 ASCO® GU Annual Meeting
Recent GU Developments and Their Clinical Implications
FEATURING
Thomas Powles,
Brian Rini
- 1,537 views
- March 7, 2024
- 6
Penn Medicine Abramson Cancer Center
Avoiding Unnecessary Operations in Prostate Cancer
FEATURING
Phillip Pierorazio
- 220 views
- November 8, 2024
- 1
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"
FEATURING
Eleni Efstathiou
- 2,673 views
- February 8, 2024
- 12
Emmanuel Seront
Update on Systemic Treatments for Metastatic Prostate Cancer
- 228 views
- November 8, 2024
- 3
Advanced Prostate Cancer Consensus Conference (APCCC)
Total Therapy Considerations in Low-Volume mHSPC: Intensification vs. De-Intensification
FEATURING
Oliver Sartor
- 220 views
- October 23, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Prostate Cancer Take-Home Messages
FEATURING
Eleni Efstathiou
- 612 views
- July 29, 2024
- 2
The View on GU | with Lalani & Wallis
Review of mCRPC Updates From ESMO 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 78 views
- October 30, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Practice-Shaping Prostate Cancer Trials
FEATURING
Eleni Efstathiou
- 149 views
- October 15, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Considerations for De-Escalation and Treatment Breaks in mHSPC Management
FEATURING
Bertrand Tombal
- 77 views
- December 6, 2024
- 1
Advanced Prostate Cancer Consensus Conference (APCCC)
Ideal Treatment Sequence After ADT + ARPI or ADT Alone for mHSPC
FEATURING
Ian Davis
- 70 views
- December 9, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Bladder and RCC Highlights
FEATURING
Karine Tawagi,
Natalie Reizine
- 119 views
- October 10, 2024
- 1
Yale Cancer Center
Key GU Cancer Trials of 2024: Treatment Advances in Urothelial and Prostate Cancer
FEATURING
Joseph Kim
- 172 views
- October 21, 2024
The View on GU | with Lalani & Wallis
Primary Radiation Treatment for Prostate Cancer
- 99 views
- September 6, 2024
- 3
Ana Aparicio
Developing Combination Therapies for Aggressive Variant Prostate Cancer
- 69 views
- January 2, 2025
Advanced Prostate Cancer Consensus Conference (APCCC)
Guidance on Optimal Candidates for Triplet Systemic Therapy in mHSPC: ADT + Docetaxel + ARPI
FEATURING
Nicholas James
- 109 views
- November 5, 2024
- 1
University of Illinois Cancer Center
Shifting Paradigms in the Treatment of Metastatic Prostate Cancer
FEATURING
Karine Tawagi
- 74 views
- December 12, 2024
COR2ED The Heart of Medical Education
ESMO 2024 Summary: Key Trial Updates on IO and Targeted Treatments in GU Cancers
FEATURING
Ray Manneh Kopp
- 90 views
- November 4, 2024
- 1
Nebraska Oncology Society
Updates on Treatment Options for mCRPC
FEATURING
Nataliya Mar
- 165 views
- July 30, 2024
The View on GU | with Lalani & Wallis
Review of GU Cancer Takeaways From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 52 views
- September 5, 2024
Fatima Karzai
Contemporary Management of De Novo Metastatic Hormone-Sensitive Prostate Cancer
- 46 views
- December 23, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Combination Systemic Therapy vs. ADT+RT in mHSPC
FEATURING
Robert Jones
- 44 views
- December 6, 2024
Beth Israel Deaconess Medical Center
Personalizing Treatment Selection in mHSPC
FEATURING
David Einstein
- 43 views
- November 20, 2024
Michigan Urological Surgery Improvement Collaborative (MUSIC)
MUSIC Experience With High-Risk Prostate Cancer
FEATURING
Alice Semarijan
- 175 views
- June 5, 2024
International Urology Cancer Summit - IUCS
Treatment (De)Intensification in mHSPC
FEATURING
Pasquale Rescigno
- 23 views
- December 4, 2024
International Urology Cancer Summit - IUCS
Patient-Friendly Fractionation for Curative Therapy of Localized Prostate Cancer
FEATURING
Alison Tree
- 72 views
- October 24, 2024
- 1
Dana-Farber Cancer Institute
Prostate Cancer Highlights From ASCO® GU 2024
FEATURING
Jacob Berchuck,
Atish Choudhury
- 335 views
- March 13, 2024
- 2
Manish Kohli
Time to Castrate Resistance in mCSPC Using Standard of Care Intensified Regimens
- 545 views
- December 22, 2023
- 3
ecancer
ESMO 2024: Optimizing the Personalization of Prostate Cancer Treatment
- 51 views
- October 22, 2024
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Summary: "Tailoring Prostate Cancer Care - EMBARK Findings, QoL and Real-World Treatment Patterns for High-Risk Biochemically Recurrent Prostate Cancer & Real World Impact of Doublet Therapy in mCSPC"
FEATURING
Stephen Freedland
- 384 views
- February 1, 2024
- 2
ecancer
Panel Discussion: Optimizing Precision Medicine in mHSPC and mCRPC
- 33 views
- December 30, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Management of Frail Patients With mHSPC
FEATURING
Maria De Santis
- 38 views
- October 25, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Radiation to the Primary in High Volume mHSPC
FEATURING
Sandy Srinivas
- 35 views
- December 4, 2024
UCLA Health
Managing Advanced Prostate Cancer Pts in Urology Clinics and When to Refer to Medical Oncologists
FEATURING
Isla Garraway
- 176 views
- March 18, 2024
- 1
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Summary: "Systemic Treatment of High-Risk Biochemically Recurrent Prostate Cancer"
FEATURING
Channing Paller
- 220 views
- February 6, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Criteria for Recommending Total Therapy in Metachronous Low-Volume mHSPC
FEATURING
Thomas Zilli
- 23 views
- December 20, 2024
Clara Hwang
Factors to Consider When Selecting Between Anti-Androgens in mCSPC
- 209 views
- February 20, 2024
- 1
Joshua Lang
Therapeutic Approach in mCSPC: Doublets, Triplets, and Patient Selection
- 304 views
- December 1, 2023
- 3
OncoAlert
Urology Year in Review: Prostate Cancer Screening, EMBARK Trial, PSMA PET, Opera Trial, and Adjuvant Therapies
FEATURING
Axel Merseburger
- 176 views
- February 20, 2024
PROSCA & BLADDR 2023
Nodal Recurrences in Prostate Cancer: What Is the Optimal Approach?
FEATURING
Piet Ost
- 206 views
- January 12, 2024
Oncology Data Advisor
Advances in Advanced Prostate Cancer
FEATURING
Tanya Barauskas Dorff
- 134 views
- January 26, 2024
OncoAlert
Year in Review: FDA Approvals in GU Oncology for 2023
FEATURING
Gil Morgan
- 122 views
- February 20, 2024
- 1
PROSCA & BLADDR 2023
When Is RT Indicated for Prostate Cancer and Should We Add ADT?
FEATURING
Paul Sargos
- 205 views
- January 12, 2024
- 1
PROSCA & BLADDR 2023
Systemic Therapy in mHSPC: Who Needs Treatment Intensification?
FEATURING
Amit Bahl
- 150 views
- January 12, 2024
- 2
UNC Lineberger Comprehensive Cancer Center
UNC Prostate Cancer Screening Updates
FEATURING
Hung-Jui Tan
- 308 views
- November 20, 2023
- 1
International Urology Cancer Summit - IUCS
Treatment Landscape of mHSPC: Doublet or Triplet
FEATURING
Neeraj Agarwal
- 237 views
- October 13, 2023
- 3
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Insights: "Salvage RT for Local Recurrence of Prostate Cancer After RT"
FEATURING
Alan Dal Pra
- 128 views
- February 20, 2024
Dana-Farber Cancer Institute
Prostate Cancer Highlights From ESMO 2023
FEATURING
Michael Serzan,
Mary-Ellen Taplin
- 239 views
- December 11, 2023
- 2
The View on GU | with Lalani & Wallis
Review of Prostate Cancer Updates From ASCO® 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 29 views
- September 6, 2024
Robert Dreicer
Current Trends in Treatment Landscape for mCRPC: Where Does Cabazitaxel and Lu-177 Fit?
- 261 views
- October 3, 2023
- 1
PROSCA & BLADDR 2023
Local Treatment of the Prostate in Synchronous mHSPC
FEATURING
Alberto Bossi
- 162 views
- January 12, 2024
- 1
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Insights: "Salvage Radiotherapy Options for Biochemical Recurrence After Radical Prostatectomy"
FEATURING
Alan Dal Pra
- 79 views
- February 20, 2024
- 1
Tisch Cancer Institute at Mount Sinai
ASTRO 2023 Insights: "Treatment Landscape for mCRPC - Lu-177-PSMA, Radium 223, and Future of RLT"
FEATURING
William Oh
- 202 views
- November 3, 2023
PROSCA & BLADDR 2023
Intermediate to High-Risk Prostate Cancer: Who Needs Treatment Intensification?
FEATURING
Piet Ost
- 112 views
- January 12, 2024
PROSCA & BLADDR 2023
Treatment Intensification of High-Risk BCR Prostate Cancer
FEATURING
Antti Rannikko
- 102 views
- January 12, 2024
ZERO Prostate Cancer
ASTRO 2023 GU Cancer Highlights
FEATURING
Howard Sandler
- 183 views
- December 27, 2023
PleXus Communications
Advancing Care for Veterans: No Longer Settling for "Enough" - Enhancing Treatment of HSPC
FEATURING
Matthew Rettig
- 94 views
- October 3, 2023
- 1
ecancer
ESMO 2023 Insights: "Benefit of Adjuvant RT Following Radical Prostatectomy for Prostate Cancer Patients"
FEATURING
Noel Clarke
- 151 views
- November 3, 2023
- 2
PROSCA & BLADDR 2023
Is Metastasis-Directed Therapy for Prostate Cancer Still Experimental?
FEATURING
Thomas Zilli
- 109 views
- January 12, 2024
OncoAlert
Treating Genitourinary Cancers With Limited Resources
FEATURING
Yüksel Ürün
- 53 views
- February 20, 2024
- 1
OncoAlert
Best of GU Radiation Oncology From ASTRO 2023
FEATURING
Sophia Kamran
- 50 views
- February 20, 2024
International Urology Cancer Summit - IUCS
Hypofractionated & Metastases-Directed Radiotherapy in Metastatic Prostate Cancer
FEATURING
Alison Tree
- 101 views
- October 13, 2023
Oncology Data Advisor
Overcoming Disparities in Prostate Cancer Care
FEATURING
Waqas Haque
- 11 views
- November 14, 2024
ecancer
ESMO 2023 Summary: "Highlights From Recent Prostate and Bladder Cancer Trials"
FEATURING
Bishal Gyawali
- 94 views
- November 15, 2023
PROSCA & BLADDR 2023
De-Escalating Strategies in HSPC
FEATURING
Bertrand Tombal
- 36 views
- January 16, 2024
PROSCA & BLADDR 2023
Lifestyle & Prevention of Complications in Advanced Prostate Cancer: Insights From APCCC
FEATURING
Aurelius Omlin
- 43 views
- January 16, 2024
Therapeutic Agents
Oncology 2024 Year in Review
Year in Review - Prostate Cancer
FEATURING
Karine Tawagi
- 308 views
- January 10, 2025
- 4
University of Illinois Cancer Center
Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer
FEATURING
Karine Tawagi,
Natalie Reizine
- 302 views
- December 2, 2024
- 6
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New Treatments
FEATURING
Guru Sonpavde
- 2,171 views
- April 16, 2024
- 12
DrTalks
Advanced Prostate Cancer Therapy: Effective and Minimally Invasive
FEATURING
Mark Hong
- 203 views
- January 20, 2025
- 2
International Urology Cancer Summit - IUCS
Evolving Strategies in First and Second-Line Treatment for mCRPC
FEATURING
Neeraj Agarwal
- 299 views
- October 23, 2024
- 2
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
FEATURING
Young Chae
- 1,228 views
- April 19, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights of Radioligand Therapies in Prostate Cancer
FEATURING
Natalie Reizine,
Karine Tawagi
- 129 views
- October 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 551 views
- July 5, 2024
- 1
Maneesh Jain
Evaluating Safety and Efficacy of T-DXd as a Subsequent Line Therapy in HER2+ mCRPC
- 138 views
- December 11, 2024
- 2
Insights from AUA 2024 Annual Meeting
AUA 2024 Insights: "Manipulating the Androgen Axis - New Agents in mHSPC and CRPC"
FEATURING
David Jarrard
- 384 views
- May 23, 2024
- 3
Cedars Sinai
Comparing Adverse Event Rates by Race Among ADT-Treated vs. Non-ADT-Treated Prostate Cancer Patients
FEATURING
Nadine Friedrich
- 177 views
- August 27, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: STAMPEDE2 Comparison P - Upfront Accelerated 177Lu-PSMA-617 in mHSPC
FEATURING
Minal Padden-Modi,
Nick James
- 72 views
- September 25, 2024
- 1
ecancer
ESMO 2024 Insights: PEACE-3 Trial - Enzalutamide Treatment Boosted by Radium-223 in mCRPC
FEATURING
Silke Gillessen
- 57 views
- October 11, 2024
Houston Methodist
Developing Local Delivery of Anti-Androgen Therapy: A Novel Treatment for Prostate Diseases
FEATURING
Pamela Munster
- 20 views
- September 19, 2024
University of Illinois Cancer Center
Overview of Homologous Recombination Deficiencies & PARPi in mCRPC
FEATURING
Karine Tawagi
- 270 views
- March 5, 2024
- 2
OncoAlert
Year in Review: Therapeutic Advances in Prostate Cancer
FEATURING
Neeraj Agarwal
- 392 views
- February 20, 2024
- 1
Penn Medicine Abramson Cancer Center
Improving QoL During and After Treatment in Prostate Cancer
FEATURING
Cailyn Chow,
Robert Caleb Kovell
- 51 views
- November 15, 2024
- 1
The View on GU | with Lalani & Wallis
Review of Prostate Cancer Updates From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 15 views
- September 5, 2024
University of Illinois Cancer Center
Diagnostic and Therapeutic Updates in mCRPC: Radioligand Therapy
FEATURING
Karine Tawagi
- 195 views
- March 5, 2024
- 5
Advanced Prostate Cancer Consensus Conference (APCCC)
Best Use of PARP Inhibitors in mCRPC With BRCA1/2 Alterations
FEATURING
Joaquin Mateo
- 27 views
- November 5, 2024
Alice Bernard-Tessier
Searching for I-O in Prostate Cancer: Unraveling the Role of Immunotherapy
- 159 views
- May 10, 2024
Cedars Sinai
Year in Review: EMBARK Study and the Evolving Role of Intensified ADT for Non-Metastatic CSPC
FEATURING
Stephen Freedland
- 273 views
- January 12, 2024
- 2
Jochen Walz
Management of Toxicities Associated With ARSi+ADT Therapy in mCSPC
- 179 views
- March 18, 2024
- 1
Total Health
The Role of Radiation Therapy in Oncology
FEATURING
Ryan Lanning
- 119 views
- July 1, 2024
ecancer
ASCO® GU 2024 Panel Discussion: "Latest in PARPi for Prostate Cancer"
- 245 views
- February 13, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Circulating Tumor Cell Enumeration and OS in mCRPC Treated With Xaluritamig
FEATURING
Andrew Armstrong
- 33 views
- October 14, 2024
Oncology Data Advisor
The Approval of Enzalutamide for nmCSPC With Biochemical Recurrence
FEATURING
Stephen Freedland
- 133 views
- January 26, 2024
- 1
Oncology Data Advisor
Exploring the TALAPRO-2 Study of Talazoparib and Enzalutamide in Prostate Cancer
FEATURING
Neeraj Agarwal,
Stephen Freedland
- 148 views
- January 26, 2024
ecancer
ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRPC Patients Treated with Lutetium-177-PSMA-617"
FEATURING
Karim Fizazi
- 79 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ABBV-706 Study - Targeted ADC for Advanced Solid Tumors"
FEATURING
Benjamin Garmezy
- 56 views
- June 11, 2024
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "[177 Lu]Lu-PSMA-617 in Taxane-Naïve Patients With mCRPC (PSMAfore)"
FEATURING
Oliver Sartor
- 348 views
- November 3, 2023
- 1
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing Side Effects of PARP Inhibitors in mCRPC
FEATURING
Elena Castro
- 21 views
- November 12, 2024
DrTalks
The Future of Cancer Treatment: Using Immunotherapy for Advanced Prostate Cancer
FEATURING
Jason Williams
- 18 views
- January 20, 2025
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CYCLONE 2 Study - Abemaciclib + Abiraterone in mCRPC"
FEATURING
Tilman Todenhöfer
- 58 views
- June 19, 2024
PROSCA & BLADDR 2023
Updates on PARPi in Prostate Cancer
FEATURING
Elena Castro
- 110 views
- January 16, 2024
- 1
PROSCA & BLADDR 2023
Radioligand Therapy for Prostate Cancer: For Whom and When
FEATURING
Ken Herrmann
- 124 views
- January 16, 2024
- 1
Moffitt Cancer Center
PSA Attainment & Reduction in Frontline mHSPC
FEATURING
Juskaran Chadha
- 142 views
- January 12, 2024
- 2
Ulka Vaishampayan
The Role of CDK4/6 Inhibitors in Metastatic Prostate Cancer
- 85 views
- February 1, 2024
- 1
International Urology Cancer Summit - IUCS
Theragnostics in Metastatic Prostate Cancer: Diagnosis and Treatment
FEATURING
Gopinath Gnanasegaran
- 251 views
- October 13, 2023
- 1
Masonic Cancer Center, University of Minnesota
Targeting RET Kinase in Neuroendocrine Prostate Cancer
FEATURING
Justin Drake
- 13 views
- November 7, 2024
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Insights: "PSA Flare in Patients With mCRPC Undergoing 177Lu-PSMA Treatment"
FEATURING
Haoran Li
- 55 views
- February 9, 2024
ImmunoTherapy Bridge 2023
Activating Innate Immunity in Prostate Cancer: From Bedside-to-Bench and Back
FEATURING
Akash Patnaik
- 65 views
- January 10, 2024
International Urology Cancer Summit - IUCS
What Is Next When ARSi and Chemo Fail in mCRPC
FEATURING
Elena Castro
- 181 views
- October 13, 2023
PROSCA & BLADDR 2023
Innovations in Nerve Sparing Robotic Prostatectomy
FEATURING
Ashutosh Tewari
- 56 views
- January 12, 2024
ImmunoTherapy Bridge 2023
Engage, Expand, Enable: Combination IO Strategy for Cold Tumors
FEATURING
James Gulley
- 60 views
- January 9, 2024
COR2ED The Heart of Medical Education
Clinical Implementation of Testing and PARPi as Monotherapy in Prostate Cancer
FEATURING
Neal Shore
- 44 views
- February 9, 2024
Masonic Cancer Center, University of Minnesota
Sacituzumab Govitecan in Advanced Prostate Cancer: Exploring Biomarkers
FEATURING
Jacque Lyman
- 49 views
- January 19, 2024
Dana-Farber Cancer Institute
ASCO® GU 2024 Insights: "Impact of Race on Outcomes to 177Lu-PSMA-617 for mCRPC"
FEATURING
Avina Rami
- 27 views
- February 20, 2024
Masonic Cancer Center, University of Minnesota
Collaborative Approaches for Tackling Diverse Phenotypes of Advanced Prostate Cancer
FEATURING
Scott Dehm
- 33 views
- January 19, 2024
Diagnostics & Biomarkers
Anwar Padhani
Prostate Cancer Diagnosis Pathway: 2024 Update
FEATURING
Anwar Padhani
- 1,362 views
- September 17, 2024
- 7
International Cancer Imaging Society (ICIS)
Prostate Cancer Detection: MRI, Image Quality, and PI-RADS Techniques
FEATURING
Patrick Asbach
- 141 views
- January 20, 2025
- 2
Penn Medicine Abramson Cancer Center
Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024
FEATURING
Daniel Lee
- 371 views
- November 12, 2024
- 1
Laurence Klotz
Visible vs. Invisible Cancers - The Genomics and Natural History
- 214 views
- November 6, 2024
- 2
Yale Cancer Center
Updates in Radioligand Therapies for Metastatic Prostate Cancer
FEATURING
William Oh
- 180 views
- November 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Prostate Cancer Highlights"
FEATURING
Natalie Reizine,
Karine Tawagi
- 575 views
- July 10, 2024
- 2
Weill Cornell Medicine Oncology & Hematology
Understanding PSMA in Advanced Prostate Cancer and Its Impact on Treatment Decisions
FEATURING
David Nanus
- 144 views
- December 10, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Recommended Imaging Standards for mHSPC in Daily Practice
FEATURING
Michael Morris
- 103 views
- November 4, 2024
- 1
Miami Cancer Institute Precision Oncology Symposium
Precision Oncology in Metastatic Prostate Cancer: Genomic Markers and Theranostics
FEATURING
Rohan Garje
- 401 views
- June 26, 2024
- 3
Michigan Urological Surgery Improvement Collaborative (MUSIC)
PSMA PET Imaging
FEATURING
Matthew Cooperberg
- 403 views
- June 5, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: INSPIRE Trial - Nivolumab and Ipilimumab in Molecularly Selected mCRPC Patients
FEATURING
Niven Mehra
- 129 views
- October 1, 2024
- 2
Anwar Padhani
MRI in Prostate Cancer Screening: Time to Reset?
FEATURING
Anwar Padhani
- 61 views
- September 17, 2024
ecancer
ESMO 2024 Insights: Best Practice in HRRm Testing in Patients With Metastatic Prostate Cancer
- 97 views
- October 16, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
PARP Inhibition (Dissected): Determining Who Benefits in mCRPC
FEATURING
Johann de Bono
- 70 views
- November 5, 2024
Jochen Walz
Unmet Needs in mCRPC After Progression on ARPIs and Chemotherapy
- 38 views
- January 23, 2025
International Cancer Imaging Society (ICIS)
Prostate Cancer Detection: Tumor Boundaries and Focal Therapy
FEATURING
Fiona Fennessy
- 13 views
- January 20, 2025
Rafee Talukder
Clinical Applications for Liquid Biopsy in GU Cancers Update
- 94 views
- October 14, 2024
- 1
Anwar Padhani
Engineering the Future of Imaging-Based Diagnostics and Therapeutics for Prostate Cancer
FEATURING
Anwar Padhani
- 98 views
- September 17, 2024
- 2
Anwar Padhani
Prostate Cancer Detection Software in 2024: What to Think About Before You Buy
FEATURING
Anwar Padhani
- 56 views
- September 17, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Relevant Prognostic and Predictive Factors in mHSPC
FEATURING
Matthew Smith
- 45 views
- October 30, 2024
Oncology Data Advisor
Interpreting PSA Values in Transgender Women for Optimal Prostate Cancer Screening
FEATURING
Stephen Freedland,
Farnoosh Nik-Ahd
- 106 views
- August 14, 2024
- 1
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing mHSPC With Early Progression on Combination Therapy
FEATURING
Christopher Sweeney
- 74 views
- November 11, 2024
- 1
University of Illinois Cancer Center
Recent Advances in Molecular-Guided Treatment of GU Malignancies
FEATURING
Natalie Reizine
- 267 views
- May 10, 2024
- 2
Advanced Prostate Cancer Consensus Conference (APCCC)
Future Changes in the Setting of mHSPC
FEATURING
Gerhardt Attard
- 47 views
- November 4, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Optimizing Escalation Strategies for mHSPC With Unfavorable PSA Declines
FEATURING
Mary-Ellen Taplin
- 33 views
- November 11, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Guidelines for Tumor Genomic Profiling in Advanced Prostate Cancer
FEATURING
Niven Mehra
- 42 views
- November 8, 2024
Oncology Data Advisor
Recent Prostate Cancer Updates
FEATURING
Ulka Vaishampayan
- 385 views
- October 9, 2023
- 2
Masonic Cancer Center, University of Minnesota
Proteomic Approaches to Nominate Drug Targets and Assess Biomarkers in Prostate Cancer
FEATURING
Justin Drake
- 58 views
- November 7, 2024
Masonic Cancer Center, University of Minnesota
Biomarkers and Biology: Treatment Resistance in Advanced Prostate Cancer
FEATURING
Joshua Lang
- 279 views
- February 20, 2024
- 1
Insights from 2024 ASCO® GU Annual Meeting
Real-World Genomic Testing Patterns in Patients With Prostate Cancer
FEATURING
Dalia Kaakour
- 181 views
- March 13, 2024
- 1
Anwar Padhani
Next-Generation Imaging for High-Risk Locally Advanced Prostate Cancer: When to Use It
FEATURING
Anwar Padhani
- 48 views
- September 17, 2024
Anwar Padhani
Prostate Cancer Screening: Lessons From the MRI Studies
FEATURING
Anwar Padhani
- 67 views
- September 17, 2024
- 1
Yale Cancer Center
Theranostics and Advanced Treatment Options for Prostate Cancer
FEATURING
Gabriela Spilberg
- 114 views
- May 6, 2024
International Urology Cancer Summit - IUCS
Liquid vs. Tumor Biopsy in Urological Tumors
FEATURING
Christian Rolfo
- 30 views
- November 4, 2024
Mark Emberton
MRI-Based Prostate Cancer Screening and Insights From the TRANSFORM Project
- 13 views
- December 10, 2024
Insights from 2024 ASCO® GU Annual Meeting
From CHAARTED Low- and High-Volume Disease to PSMA PET Imaging Volume in mHSPC
FEATURING
Lena Unterrainer
- 108 views
- March 5, 2024
COR2ED The Heart of Medical Education
Precision Oncology in Practice: Testing to Treatment in Lung and Prostate Cancer
FEATURING
Fernando López-Ríos
- 35 views
- September 26, 2024
PROSCA & BLADDR 2023
The Role of PSMA-PET/CT in Primary Staging, for Follow-Up After Radical Treatment and for Advanced Prostate Cancer
FEATURING
Karolien Goffin
- 211 views
- January 12, 2024
- 1
ecancer
ESMO 2024 Summary: Understanding the Use of PARPi Combinations to Treat Patients With mCRPC
- 25 views
- October 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Predictive Tumor Suppressor Gene Signature for Early Progression in mHSPC
FEATURING
Marta Garcia De Herreros
- 24 views
- September 20, 2024
Oncology Data Advisor
National Cancer Prevention Month: Lowering Prostate Cancer Risk
FEATURING
Stephen Freedland,
William Aronson
- 52 views
- March 14, 2024
- 1
PROSCA & BLADDR 2023
Prostate Cancer Screening and Organized Testing
FEATURING
Antti Rannikko
- 131 views
- January 12, 2024
Houston Methodist
Novel Approaches in Oncology: Early Interception & BRCA Advances in Prostate & Pancreatic Cancer Therapy
FEATURING
Pamela Munster
- 24 views
- September 18, 2024
PROSCA & BLADDR 2023
Clinical Implications of Genomic Alterations in Prostate Cancer
FEATURING
David Olmos
- 125 views
- January 12, 2024
- 1
PROSCA & BLADDR 2023
How Should Prostate Cancer Be Diagnosed: Targeted + Systematic Biopsy
FEATURING
Roderick van den Bergh
- 101 views
- January 16, 2024
ecancer
The Value of Identifying BRCA1 & BRCA2 Mutations for mCRPC Outcomes
FEATURING
Guilhem Roubaud
- 52 views
- April 26, 2024
International Urology Cancer Summit - IUCS
Today Biomarkers and Targets in GU Cancers
FEATURING
Pasquale Rescigno
- 233 views
- October 24, 2023
ecancer
ASCO® GU 2024 Insights: "Remote Delivery of Cancer Genetic Testing in Men With Metastatic Prostate Cancer"
FEATURING
Bruce Montgomery
- 63 views
- February 13, 2024
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "PSMA PET-Directed Outcomes in mHSPC: Implications for the STAMPEDE2 Trial Design"
FEATURING
Hoda Abdel-Aty
- 100 views
- January 12, 2024
Oncology Data Advisor
The Urologist and Oncologist Perspectives on Advancements and Disparities in Prostate Cancer
FEATURING
Stephen Freedland,
Ulka Vaishampayan
- 14 views
- November 5, 2024
UNC Lineberger Comprehensive Cancer Center
UNC Update on Prostate Cancer Screening
FEATURING
Marc Bjurlin
- 88 views
- December 5, 2023
- 1
PROSCA & BLADDR 2023
Should Extended LND Still Be SOC for High-Risk Prostate Cancer?
FEATURING
Jochen Walz
- 82 views
- January 12, 2024
PROSCA & BLADDR 2023
Liquid Biopsy as a Treatment Selector in mCRPC
FEATURING
Bram De Laere
- 53 views
- January 16, 2024
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Current Status of PSMA PET in the US
FEATURING
Thomas Hope
- 10 views
- June 5, 2024
Insights from 2023 ASCO® Annual Meeting
Assessment and Decision Tools for Balancing Survival and Quality of Life
FEATURING
Elizabeth Kessler
- 97 views
- October 3, 2023
ecancer
ASCO® GU 2024 Insights: "Stockholm3 Validation in a Multi-Ethnic Cohort for Prostate Cancer (SEPTA) Detection"
FEATURING
Scott Eggener
- 34 views
- February 13, 2024
Dana-Farber Cancer Institute
New and Ongoing Research Efforts at the Dana-Farber Lynch Syndrome Center
FEATURING
Asaf Maoz
- 13 views
- July 5, 2024
PROSCA & BLADDR 2023
How Should Prostate Cancer Be Diagnosed: Targeted Biopsies Alone Should Be the Standard of Care
FEATURING
Johan Stranne
- 20 views
- January 16, 2024
ecancer
DNA Methylation Profile of Prostate Cancer Aggressiveness in Ghana
FEATURING
Alexandra Lindsey Djomkam Zune
- 26 views
- February 8, 2024
Disease Overview
University of Miami Sylvester Comprehensive Cancer Center
Precision Therapies for Prostate Cancer
FEATURING
Marijo Bilusic
- 424 views
- August 20, 2024
- 5
Yale Cancer Center
Surgical Options for the Care of Prostate Cancer
FEATURING
Michael Leapman,
Eric Winer
- 159 views
- December 11, 2024
- 1
Ana Aparicio
Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment, Monotherapy vs. Combination Therapy
- 1,659 views
- December 4, 2023
- 13
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
Radiation Oncology: Basic Principles and Updates in 2024
FEATURING
Jonathan Chen
- 219 views
- July 18, 2024
- 3
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Surgery for High-Risk Prostate Cancer
FEATURING
James Peabody
- 174 views
- June 5, 2024
- 1
Houston Methodist
Cancer Prevention, Control, and Population Sciences: Insights From Prostate Cancer and Beyond
FEATURING
Jennifer Cullen
- 72 views
- September 10, 2024
University of Illinois Cancer Center
Survivorship in Radiation Oncology Patients
FEATURING
Christina Son
- 17 views
- December 18, 2024
Yale Cancer Center
The Importance of Yearly Check-Ups for Men and Screening for Urologic Cancers
FEATURING
Michael Karellas
- 59 views
- February 13, 2024
- 1
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Insights: "Patient-Provider Rurality and Outcomes in Older Men With Prostate Cancer"
FEATURING
Avirup Guha
- 57 views
- February 20, 2024
Oncology Data Advisor
Great American Smokeout: The Link Between Smoking and Prostate Cancer
FEATURING
Stephen Freedland
- 25 views
- January 26, 2024
PROSCA & BLADDR 2023
QoL in Patients With Advanced Prostate Cancer Who Are Living Longer: Managing Cognitive Changes
FEATURING
Daniele Raggi
- 65 views
- January 16, 2024
Masonic Cancer Center, University of Minnesota
Innate Lymphoid Cells and Cancer: What’s the Connection?
FEATURING
Michael Caligiuri
- 29 views
- February 23, 2024
PROSCA & BLADDR 2023
Improving Psychological Well-Being of Advanced Prostate Cancer Patients
FEATURING
Tania Estapé
- 33 views
- January 16, 2024
Oncology Data Advisor
Raising Awareness of Prostate Cancer in Transgender Women
FEATURING
Farnoosh Nik-Ahd,
Stephen Freedland
- 43 views
- October 9, 2023
NYU Langone
What Happens Under the Beam - Radiation Oncology for the Primary Care Physician
FEATURING
Oren Cahlon
- 87 views
- February 5, 2024
- 1
Case Studies
Yale Cancer Center
Expert Discussions and Case Insights in Advanced GU Cancers
- 75 views
- October 21, 2024
International Urology Cancer Summit - IUCS
Interactive Case Quiz: Urological Tumors Treatment Discussion
FEATURING
Yuksel Urun
- 41 views
- October 24, 2024
Andrew Hahn
Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an "Overlap Syndrome"
- 342 views
- December 13, 2023
PleXus Communications
Adverse Effects of Treatment for mCSPC and Their Multidisciplinary Management
FEATURING
Grace Cullen
- 94 views
- October 4, 2023
Total Health
Case-Based Clinical Updates in Prostate Cancer: 57 y/o With De Novo M1 Disease With Liver Mets
- 105 views
- October 18, 2023
ecancer
57 y/o Patient With Triple Coronary Bypass and PSA>900 ng/ml: High Risk De Novo Metastatic Prostate Cancer Case Discussion
FEATURING
Guilhem Roubaud
- 40 views
- April 26, 2024
Total Health
Case-Based Clinical Updates in Prostate Cancer: 63 y/o Male With Left Seminal Vesicle Invasion
- 79 views
- October 18, 2023
Total Health
Case-Based Clinical Updates in Prostate Cancer: 77 y/o Practicing Physician With mCSPC
- 106 views
- October 18, 2023
Total Health
Case-Based Clinical Updates in Prostate Cancer: CRPC Patient Post-Abiraterone & Docetaxel
- 28 views
- October 18, 2023
PROSCA & BLADDR 2023
PCaGoal: Prostate Cancer Patients Football Team at FC Porto
FEATURING
Diogo Nunes-Carneiro
- 18 views
- January 18, 2024